National Academies Press: OpenBook

Forum on Regenerative Medicine: 2021 Annual Report (2022)

Chapter:Forum Membership

« Previous: Public Workshop
Suggested Citation:"Forum Membership." National Academies of Sciences, Engineering, and Medicine. 2022. Forum on Regenerative Medicine: 2021 Annual Report. Washington, DC: The National Academies Press. doi: 10.17226/26583.

Below is the uncorrected machine-read text of this chapter, intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text of each book. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Forum Membership Tim Coetzee, Ph.D. (Co-Chair) Michael May, Ph.D. Rachel Salzman, D.V.M. National Multiple Sclerosis Society Centre for Commercialization of American Society of Gene & Cell Regenerative Medicine Therapy Katherine Tsokas, J.D. (Co-Chair) Janssen, Inc. Canada Richard McFarland, Ph.D., M.D. Ivonne Schulman, M.D. Advanced Regenerative Manufacturing National Institute of Diabetes and Sangeeta N. Bhatia, M.D., Ph.D. Institute Digestive and Kidney Diseases Massachusetts Institute of Technology Jack T. Mosher, Ph.D. Jay Siegel, M.D. (retired) Philip John Brooks, Ph.D. International Society for Stem Cell Johnson & Johnson National Center for Advancing Research Translational Sciences Lana Skirboll, Ph.D., M.S. Amy Patterson, M.D. Sanofi George Q. Daley, M.D., Ph.D. National Heart, Lung, and Blood Harvard Medical School; Boston Institute Susan L. Solomon, J.D. Children’s Hospital and Dana-Farber The New York Stem Cell Foundation Cancer Institute Duanqing Pei, Ph.D. Chinese Academy of Sciences Martha Somerman, D.D.S., Ph.D. (until Rena D’Souza, D.D.S., M.D., Ph.D. (from May 2021) June 2021) Thomas Petersen, M.D., Ph.D. National Institute of Dental and National Institute of Dental and United Therapeutics Corporation Craniofacial Research Craniofacial Research Anne Plant, Ph.D. Michael Steinmetz, Ph.D. Larry Goldstein, Ph.D. National Institute of Standards and National Eye Institute Sanford Consortium for Regenerative Technology Sohel Talib, Ph.D. Medicine; University of California, San Kimberlee Potter, Ph.D. California Institute for Regenerative Diego, School of Medicine U.S. Department of Veterans Affairs Medicine Candace Kerr, M.S., Ph.D. Daniel Weiss, M.D., Ph.D. National Institute on Aging David Rampulla, Ph.D. National Institute of Biomedical International Society for Cell & Gene Robert S. Langer, Sc.D. Imaging and Bioengineering Therapy Massachusetts Institute of Technology Derek Robertson, M.B.A., J.D. Maryland Michael Werner, J.D. Cato T. Laurencin, M.D., Ph.D. Alliance for Regenerative Medicine Sickle Cell Disease Association Connecticut Convergence Institute for Translation in Regenerative Celia M. Witten, Ph.D., M.D. Kelly Rose, Ph.D. Engineering; University of Connecticut U.S. Food and Drug Administration Burroughs Wellcome Fund Timothy LaVaute, Ph.D. Krishnendu Roy, Ph.D. Georgia Claudia Zylberberg, Ph.D. National Institute of Neurological Institute of Technology Akron Biotech Disorders and Stroke Terry Magnuson, Ph.D. Krishanu Saha, Ph.D. University of North Carolina at Chapel University of Wisconsin–Madison Hill (AS OF DECEMBER 2021) 2021 Annual Report | 5

Next: Forum Sponsors »
Forum on Regenerative Medicine: 2021 Annual Report Get This Book
MyNAP members save 10% online.
Login or Register to save!
Download Free PDF

The National Academies of Sciences, Engineering, and Medicine's Forum on Regenerative Medicine (the forum) provides a convening mechanism for interested parties from academia, industry, government, patient and provider organizations, regulatory bodies, foundations, societies, associations, and others. The forum identifies existing and potential barriers to scientific and therapeutic advances; discusses opportunities to assist in facilitating more effective partnerships among key stakeholders; examines the impact that current policies have on the discovery, development, and translation of regenerative medicine therapies; considers the unique challenges of identifying, validating, and bringing regenerative medicine applications to market; and explores the ethical, legal, and social issues posed by advances in regenerative medicine.

During 2021, the forum members continued to focus on two broad areas through their two working groups: Regenerative Engineering and Gene Therapy and Systems Thinking. The members and staff also continued to explore challenges and discuss possible solutions in a number of other areas relevant to the development of regenerative medicines, including communication, workforce development, cost of and access to therapies, and regulatory and legislative affairs. This publication describes the activities of the forum during 2021.

  1. ×

    Welcome to OpenBook!

    You're looking at OpenBook,'s online reading room since 1999. Based on feedback from you, our users, we've made some improvements that make it easier than ever to read thousands of publications on our website.

    Do you want to take a quick tour of the OpenBook's features?

    No Thanks Take a Tour »
  2. ×

    Show this book's table of contents, where you can jump to any chapter by name.

    « Back Next »
  3. ×

    ...or use these buttons to go back to the previous chapter or skip to the next one.

    « Back Next »
  4. ×

    Jump up to the previous page or down to the next one. Also, you can type in a page number and press Enter to go directly to that page in the book.

    « Back Next »
  5. ×

    To search the entire text of this book, type in your search term here and press Enter.

    « Back Next »
  6. ×

    Share a link to this book page on your preferred social network or via email.

    « Back Next »
  7. ×

    View our suggested citation for this chapter.

    « Back Next »
  8. ×

    Ready to take your reading offline? Click here to buy this book in print or download it as a free PDF, if available.

    « Back Next »
Stay Connected!